Free Trial

Algert Global LLC Increases Stock Position in Cognex Corporation $CGNX

Cognex logo with Computer and Technology background

Key Points

  • Algert Global LLC increased its holdings in Cognex Corporation by 16.6% in Q1, owning approximately 95,387 shares worth $2.8 million as of the latest SEC filing.
  • Cognex reported earnings per share (EPS) of $0.25 for the last quarter, beating estimates by $0.02, with revenue rising 4.2% year-over-year.
  • The company has announced a quarterly dividend of $0.08 per share, with a dividend yield of 0.7%, to be paid on August 28th.
  • Need better tools to track Cognex? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Algert Global LLC increased its stake in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 16.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,387 shares of the scientific and technical instruments company's stock after acquiring an additional 13,590 shares during the quarter. Algert Global LLC owned about 0.06% of Cognex worth $2,845,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Covestor Ltd increased its stake in Cognex by 17.6% in the first quarter. Covestor Ltd now owns 2,223 shares of the scientific and technical instruments company's stock valued at $66,000 after purchasing an additional 332 shares during the period. Centaurus Financial Inc. increased its stake in Cognex by 16.0% in the fourth quarter. Centaurus Financial Inc. now owns 3,267 shares of the scientific and technical instruments company's stock valued at $117,000 after purchasing an additional 450 shares during the period. OneDigital Investment Advisors LLC increased its stake in Cognex by 7.4% in the first quarter. OneDigital Investment Advisors LLC now owns 7,698 shares of the scientific and technical instruments company's stock valued at $230,000 after purchasing an additional 532 shares during the period. GAMMA Investing LLC increased its stake in Cognex by 155.3% in the first quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company's stock valued at $32,000 after purchasing an additional 646 shares during the period. Finally, UMB Bank n.a. increased its stake in Cognex by 105.5% in the first quarter. UMB Bank n.a. now owns 1,280 shares of the scientific and technical instruments company's stock valued at $38,000 after purchasing an additional 657 shares during the period. 88.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CGNX. Citigroup reiterated a "neutral" rating and set a $37.00 price target (up from $30.00) on shares of Cognex in a research note on Monday, July 14th. Melius upgraded shares of Cognex from a "hold" rating to a "buy" rating and set a $60.00 price target on the stock in a research note on Thursday, July 10th. Robert W. Baird boosted their price target on shares of Cognex from $30.00 to $32.00 and gave the stock a "neutral" rating in a research note on Monday, June 16th. Needham & Company LLC boosted their price target on shares of Cognex from $36.00 to $45.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. Finally, DA Davidson boosted their price target on shares of Cognex from $32.00 to $35.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $42.31.

Read Our Latest Report on CGNX

Cognex Price Performance

Shares of NASDAQ CGNX traded down $0.5550 on Monday, hitting $44.2050. The company's stock had a trading volume of 1,111,652 shares, compared to its average volume of 2,099,147. Cognex Corporation has a 12-month low of $22.67 and a 12-month high of $45.03. The company has a market capitalization of $7.42 billion, a price-to-earnings ratio of 62.30 and a beta of 1.47. The stock has a 50 day moving average of $35.85 and a 200-day moving average of $32.04.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The company had revenue of $249.09 million for the quarter, compared to the consensus estimate of $246.70 million. During the same quarter in the prior year, the firm earned $0.23 earnings per share. The company's revenue for the quarter was up 4.2% compared to the same quarter last year. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. Sell-side analysts expect that Cognex Corporation will post 0.61 EPS for the current fiscal year.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 28th. Investors of record on Thursday, August 14th will be given a dividend of $0.08 per share. The ex-dividend date of this dividend is Thursday, August 14th. This represents a $0.32 annualized dividend and a yield of 0.7%. Cognex's dividend payout ratio is 45.07%.

Cognex Company Profile

(Free Report)

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Featured Stories

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Should You Invest $1,000 in Cognex Right Now?

Before you consider Cognex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.

While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines